| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.29 | 0.08 |